Centre Paul Strauss

Strasbourg, Bas-rhin 67091

0 studies enrolling now · 5 studies all time

What they study most

Advanced or Metastatic Gastric or Gastroesophageal Cancer, Advanced or Metastatic Solid Tumor, Breast Cancer, Cancer of the Prostate, Metastatic Pancreatic Adenocarcinoma, Myeloid or Lymphoid Neoplasms (MLN), Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Solid Tumors

Studies at this site

• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] — Running, not enrolling
• Futibatinib in Patients With Specific FGFR Aberrations — Stopped early
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors — Completed
• Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed